The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.

The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.

BACKGROUND: Advanced glycation end products (AGE) and their receptors (RAGE) have been implicated in cancer development through their proinflammatory capabilities. However, prospective data on their association with cancer of specific sites, including pancreatic cancer, are limited. METHODS: Prediag...

Full description

Bibliographic Details
Main Authors: Grote, V, Nieters, A, Kaaks, R, Tjønneland, A, Roswall, N, Overvad, K, Nielsen, MR, Clavel-Chapelon, F, Boutron-Ruault, M, Racine, A, Teucher, B, Lukanova, A, Boeing, H, Drogan, D, Trichopoulou, A, Trichopoulos, D, Lagiou, P, Palli, D, Sieri, S, Tumino, R, Vineis, P, Mattiello, A, Argüelles Suárez, M, Duell, E, Sánchez, M
Format: Journal article
Language:English
Published: 2012

Similar Items